Back
First Trust Nasdaq BuyWrite Income ETF Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Buy
71
FTQI
First Trust Nasdaq BuyWrite Income ETF
Last Price:
$21.00
Seasonality Move:
-0.13%
Buy
60
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$784.62
Seasonality Move:
12.13%
Buy
71
First Trust Nasdaq BuyWrite Income ETF (FTQI)
is a Buy
Is First Trust Nasdaq BuyWrite Income ETF a Buy, Sell or Hold?
-
The current First Trust Nasdaq BuyWrite Income ETF [FTQI] share price is $21.01. The Score for FTQI is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
FTQI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $784.97. The Score for REGN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FTQI Stock Price Chart
What is First Trust Nasdaq BuyWrite Income ETF's stock price today?
-
The First Trust Nasdaq BuyWrite Income ETF share price today is $21.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FTQI is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $784.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing slight buying pressure.
FTQI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 57.39 | Buy |
| Chaikin Money Flow: | 77840 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.51 - 20.99) | Buy |
| Bollinger Bands (100): | (20.26 - 20.92) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 212.63 | Buy |
| Relative Strength Index (14 RSI): | 67.49 | Buy |
| Chaikin Money Flow: | 125325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (724.62 - 777.16) | Buy |
| Bollinger Bands (100): | (556.48 - 712.42) | Buy |
FTQI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.76 | Buy |
| 20-day SMA: | 20.84 | Buy |
| 50-day SMA: | 20.8 | Buy |
| 200-day SMA: | 19.83 | Buy |
| 8-day EMA: | 20.85 | Buy |
| 20-day EMA: | 20.81 | Buy |
| 50-day EMA: | 20.74 | Buy |
| 200-day EMA: | 20.3 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 768.25 | Buy |
| 20-day SMA: | 747.3 | Buy |
| 50-day SMA: | 695.26 | Buy |
| 200-day SMA: | 602.28 | Buy |
| 8-day EMA: | 643.63 | Buy |
| 20-day EMA: | 389.89 | Buy |
| 50-day EMA: | 188.67 | Buy |
| 200-day EMA: | 52.17 | Buy |
First Trust Nasdaq BuyWrite Income ETF Earnings Growth & FTQI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $1.14 per share.
First Trust Nasdaq BuyWrite Income ETF Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||